Pablo Palazón‐Riquelme

418 citations
6 papers · 289 indexed · h-index 5
Topics
Inflammasome and immune disorders (5 papers)IL-33, ST2, and ILC Pathways (3 papers)Heme Oxygenase-1 and Carbon Monoxide (2 papers)

In The Last Decade

Pablo Palazón‐Riquelme

6 papers receiving 284 citations

Peers

Pablo Palazón‐Riquelme
Comparison fields: 5 of 75
  • Molecular Biology 216
  • Immunology 89
  • Epidemiology 39
  • Surgery 30
  • Oncology 30
Replace Mehdi Tourani with:
Mehdi Tourani Iran
Kaixin Liang United States
A Batra Germany
Xingsheng Ye China
Hasan Halit Öz Germany
David Jetton United States
Karim H. Shalaby Canada
Yoshitaka Oyama Japan
Toshifumi Hibi Japan
Pablo Palazón‐Riquelme relative to Mehdi Tourani Iran Mehdi Tourani's profile →
Citations per field
00.5×1.5×2.0×
Mehdi Tourani · 1×
Citations per year

Countries citing papers authored by Pablo Palazón‐Riquelme

Since Specialization
Citations

This map shows the geographic impact of Pablo Palazón‐Riquelme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Palazón‐Riquelme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Palazón‐Riquelme more than expected).

Fields of papers citing papers by Pablo Palazón‐Riquelme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Palazón‐Riquelme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Palazón‐Riquelme. The network helps show where Pablo Palazón‐Riquelme may publish in the future.

Co-authorship network of co-authors of Pablo Palazón‐Riquelme

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Palazón‐Riquelme. A scholar is included among the top collaborators of Pablo Palazón‐Riquelme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Palazón‐Riquelme. Pablo Palazón‐Riquelme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 13
2 66
3 37
4 31
5 138
6 4

About Pablo Palazón‐Riquelme

Pablo Palazón‐Riquelme is a scholar working on Immunology, Gastroenterology and Parasitology, having authored 6 papers that have together received 289 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Immunology (89 citations), Biological Psychiatry (8 citations) and Molecular Biology (216 citations). Pablo Palazón‐Riquelme has collaborated with scholars based in United Kingdom, Italy and France. Frequent co-authors include Gloria López‐Castejón, Jack Green, David Brough, Carolina Pellegrini, Fatima Martín‐Sánchez, Jonathan D. Worboys, Michael J. Daniels, Elena Redondo‐Castro, Philipp Kaldis and Víctor S. Tapia. Their work appears in journals such as Journal of Biological Chemistry, British Journal of Pharmacology and EMBO Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026